文献速递哮喘

可治疗特征可在重症哮喘注册研究中识别并预测未来急性加重

Treatable traits can be identified in a severe asthma registry and predict future exacerbations.
PubMed 文献 · Respirology · 2018-09-19

本研究基于澳大利亚重症哮喘网络数据库(SAWD),纳入434例重症哮喘和102例非重症哮喘患者,将已发表的可治疗特征映射到注册数据字段,并在基线和每6个月随访24个月。结果识别出肺部、肺外及行为/风险因素三个领域的24个可治疗特征,重症哮喘患者表达更多可治疗特征,其中10个特征可预测未来急性加重风险。

要点

  • 重症哮喘注册数据可识别24个可治疗特征,覆盖肺、肺外及行为领域。
  • 重症哮喘患者比非重症哮喘表达更多肺部和肺外可治疗特征。
  • 10个特征预测未来加重,包括易加重、抑郁、吸入装置多重用药等。

核心结论

  • 可治疗特征可通过重症哮喘注册研究进行评估,且特定特征与未来哮喘急性加重风险相关。

研究设计与样本

  • 研究基于澳大利亚重症哮喘网络数据库(SAWD),纳入434例重症哮喘参与者和102例非重症哮喘对照,基线及每6个月随访24个月。

主要发现

  • 共识别24个可治疗特征,分属肺部、肺外和行为/风险因素三个领域。
  • 重症哮喘患者比非重症哮喘表达更多肺部和肺外可治疗特征。
  • 过敏致敏、上气道疾病、气流受限、嗜酸性炎症和频繁加重在重症哮喘中常见。
  • 10个特征预测未来加重风险,最强的包括易加重、抑郁、吸入装置多重用药、声带功能障碍和阻塞性睡眠呼吸暂停。

临床怎么用

  • 临床可利用重症哮喘注册数据系统评估可治疗特征,以识别未来急性加重高风险患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: A new taxonomic and management approach, termed treatable traits, has been proposed for airway diseases including severe asthma. This study examined whether treatable traits could be identified using registry data and whether particular treatable traits were associated with future exacerbation risk. METHODS: The Australasian Severe Asthma Web-Based Database (SAWD) enrolled 434 participants with severe asthma and a comparison group of 102 participants with non-severe asthma. Published treatable traits were mapped to registry data fields and their prevalence was described. Participants were characterized at baseline and every 6 months for 24 months. RESULTS: In SAWD, 24 treatable traits were identified in three domains: pulmonary, extrapulmonary and behavioural/risk factors. Patients with severe asthma expressed more pulmonary and extrapulmonary treatable traits than non-severe asthma. Allergic sensitization, upper-airway disease, airflow limitation, eosinophilic inflammation and frequent exacerbations were common in severe asthma. Ten traits predicted exacerbation risk; among the strongest were being prone to exacerbations, depression, inhaler device polypharmacy, vocal cord dysfunction and obstructive sleep apnoea. CONCLUSION: Treatable traits can be assessed using a severe asthma registry. In severe asthma, patients express more treatable traits than non-severe asthma. Traits may be associated with future asthma exacerbation risk demonstrating the clinical utility of assessing treatable traits.

来源:Respirology,查看原文。版权归原作者所有。

引用

  1. McDonald VM, Hiles SA, Godbout K, et al. Treatable traits can be identified in a severe asthma registry and predict future exacerbations. Respirology. 2018. PMID: 30230137. doi:10.1111/resp.13389

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。